Ravi Kumar
Pharmaceutical Industry
Arkay Therapeutics
Australia
Biography
Dr. Ravi Kumar has served as the President and CEO since 2014. He founded ARKAY with a mission to provide long-term glycemic control to Type II diabetes patients. Dr. Kumar has a unique combination of expertise in metabolic, cardiovascular and chronic inflammatory diseases. He developed the scientific rationale, the product concept and the clinical development strategies for RK-01. Since Type II diabetes runs in his family, he knows first-hand the challenges of diabetes patients, limitations of the currently marketed drugs and more importantly the devastating consequences of diabetes-related complications
Research Interest
diabetes
